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ABSTRACT 
 
 
A  simple  and  efficient  synthetic  protocol  has  been  developed  using    iodine,  three-component 
one-pot reaction involving  2-aminophenol,  dialkylacetylenedicarboxylate  and  substituted beta-
nitrostyrene.  Utilizing  this protocol,  a  variety  of  novel  pyrrolo-1,4-benzoxazine  derivatives  
were  synthesized  in good to excellent  yields. 
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Iodine Mediated One-pot Three Component Synthesis of a Novel 
Tricyclic Pyrrolo-1,4-Benzoxazines 
 
 
 
 
1.1 INTRODUCTION 
The preparation of complex molecules by conventional method is not an easy task due to 
extraction and purification in each step, and time consuming as well as synthetically inefficient as 
it produces large number of waste.  Multicomponent reactions leads to greener synthesis where 
generally in one pot three different substrates react and join through covalent bond.  MCRs offer 
remarkable advantages like convergence, operational simplicity, facile automation, reduction in 
number of workup, extraction, purification process and hence minimize  waste generation, and 
rendering the transformations green.1  One-pot MCRs reduce energy and manpower as it is giving 
products in short reaction times with higher yields.  In drug discovery, organic synthesis and 
material science MCRs got the highest attraction.2   Green chemistry strongly influence chemical 
research and there is an insistence on the use of greener reaction condition.3 
 Iodine is inexpensive, nontoxic, readily available catalyst used for various organic 
transformatios.4,5 It has high tolerence in air as well as in moisture and can be easily removed by 
using reducing agents. Now a days the development of a safe, atom-efficient acid and/or metal-
catalyzed organic process is one of the most important challenges in green chemistry. While acid 
and/or metal catalysis remains the most widely used type of catalysis, the commonly used acid 
and/or metal catalysts continue to pose serious health and safety problems. Moreover, the mild 
Lewis acidity of iodine has enhanced its utility for several organic transformations starting from 
minor catalytic amounts to higher stoichiometric levels.  
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Many of the iodine-mediated reactions6 features mild reaction conditions, greater stereo- 
and regioselectivities, and short reaction times. Most of these reactions are carried out by 
multicomponent and/or domino reaction sequences. Multicomponent7,10 and domino8 reactions 
allow the creation of several bonds in a single operation and are one of the important synthetic 
tools for the creation of molecular diversity and complexity.9 They are also extremely user- and 
environment-friendly due to the step reduction and high atom-economy associated with their use. 
  Pyrrolo-1,4-benzoxazine have attracted much more attention. Due to their important 
biological activity, they are, in recent years broadly investigated and utilized in the pharmaceutical 
industry. 
 
 
 
                                                           Pyrrolo-1,4-benzoxazine 
 
 
1.2 BIOLOGICAL & PHARMACEUTICAL ACTIVITY 
Pyrrolo-1,4-benzoxazine became highly important heterocyclic molecule as it contains 
both the highly active heterocyclic moiety pyrrole and benzoxazine.  Benzoxazines can be found 
in drugs11,12 and natural products13 such as Cappamensin A extracted from Capparin sikkimensis 
which has significant in vitro cytotoxicity against various human tumor cell lines.   However, the  
broad potential  biological  activities  for  these  compounds  have  not  yet  been  fully  explored  
perhaps  due  to  the  lack  of  general  methods  for the  synthesis  of  the  unique  tricyclic  core. 
 
                                       Fig 1. Some benzoxazine derived drugs and natural products. 
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 Pyrrolo-1,4-benzoxzine can be used as a drug14,15 e.g. benzopyrimidopyrrolo-oxazinedione 
(BPO) which has a activity of CFTR inhibitors for polycystic kidney diseases. 3-Phenyl-1H-
pyrrolo[2,1-c][1,4]oxazin-1-one can be used as a precursor for the synthesis of muscle relaxant 
agents. 
 
                                 Fig 2. Some pyrrolo-1,4-benzoxazine derived drugs. 
 
1.3 BACKGROUND 
Because of the highly pharmaceutical and biological activity of pyrrolo-1,4-benzoxzine 
derivatives were synthesized and those are, 1. The synthesis of pyrrolo[2,1-c][1,4]benzoxazines 
via intramolecular nucleophilic substitution of aromatic fluoride as elegantly demonstrated by 
Pujol’s group (Scheme 1, Eq. 1).16  2. Hands et al. who have described the synthesis of 2-
substituted-6-azaindoles via condensation of Li2-(N-Boc)-3-amino-4-picoline with appropriately 
chosen Weinreb amides(Scheme 2, Eq. 2).17  3. Based on the above 2 literatures, fused tetracyclic 
7-azaindolo[2,1-c][1,4]benzoxazine scaffold has been synthesized (Scheme 3, Eq.3).18  4. 
Synthesis of pyrrole and indole quinoxalinone and oxazinone derivatives by intramolecular 
copper-catalyzed reactions  (Scheme 4, Eq.4).19  5. FeCl3 catalyzed One-pot  multicomponent  
synthesis  of  novel  tricyclic pyrrolo[2,1-c][1,4]benzoxazines  (Scheme 5, Eq.5). 20  
However, most of these methods possess several disadvantages such as low yields of 
products, long reaction time, harsh reaction conditions,21 tedious work-ups and large amount of 
toxic metal waste with solvent,19 requirement of inert atmosphere and use of stoichiometric or 
relatively expensive reagents.  All these processes contain a high amount of disadvantage as all 
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the reactions are either metal/acid catalyzed which are highly hazardous and not comes under green 
protocol. 
As part  of  our  current  studies22 on  the  development  of  new greener methodologies  for 
the synthesis of  heterocyclic  systems, herein we propose to iodine for the synthesis of pyrrolo -
1,4-benzoxazines.  Iodine can activate (i) carbon-carbon double bond (ii) carbon-carbon triple 
bond (iii) enamine, thioamide, and hydrazine (iv) carbonyl and imine (v) orthoformate.  Because 
of its non-combustible, inexpensive, non-toxic, and ready availability, high tolerance to air and 
moisture and can be easily removable from reaction mixture using reducible agent, it is highly 
used in organic transformations starting from minor catalytic amount to stoichiometric amount.  
Recently it is used hugely in heterocyclic synthesis.  Based on these results, we aimed to investigate 
if it would be possible to develop an iodine mediated21 one pot protocol to synthesize pyrrolo-1,4-
benzoxazines. So far to the best of our knowledge, there are no reports on iodine mediated 
synthesis of pyrrolo-1,4-benzoxazine derivatives.  Details of this investigation are described in the 
following chapter. 
 
Scheme 1: A Convenient Synthesis of Pyrrolo[2,1-c][1,4] benzoxazines  
 
 
Eq 1. Intramolecular aromatic nucleophilic substitution. 
   
Scheme 2: 
 
 
Eq 2. Pyrrole ring construction 
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Scheme 3: Synthesis of a novel tetracyclic azaindolo[2,1-c][1,4]benzoxazine ring system 
 
 
 
                                Eq 3. Synthesis of 7-azaindolo[2,1-c][1,4]benzoxazine 
 
   
 
 Scheme 4: Synthesis of pyrrole and indole quinoxalinone and oxazinone derivatives by 
                     intramolecular copper-catalyzed reactions 
 
Eq 4. Cu- catalyzed intramolecular N-arylation. 
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Scheme 5: One-pot  multicomponent  synthesis  of  novel  tricyclic  
                  4  pyrrolo[2,1-c][1,4]benzoxazines 
 
                                Eq 5. Synthesis of pyrrolo[2,1-c][1,4]benoxazine derivative 
 
Our method: 
 
1.4 RESULT AND DISCUSSION 
In our investigation initially we have selected 2-amino phenol, 
dimethylacetylenedicarboxylate and beta-nitrostyrene as a test reaction and the reaction conditions 
like temperature, catalyst (iodine) 1equiv., solvent and time were varied (Table 1). we screened a 
series of Brønsted acids and lewies acids for this reaction, such as HOAc, MeSO3H, CF3SO3H, 
TFA, PTSA , but the desired product was obtained in a low yield. When we performed the reaction 
in the presence of iodine at low temparature observed the desired product with low yield. The best 
result was observed temperature at 82 OC.  After several optimization processes we found that the 
mixture of equimolar amount of 2-aminophenol, DMAD and beta-nitrostyrene in presence of 1eq. 
iodine in acetonitrile solvent at 82 OC resulted in 85% isolated yield of methyl 4-oxo-2-phenyl-
4H-pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate. We tried to investigate in situ generation of 
nitrostyrene from aromatic aldehyde and nitromethane as four component reaction which gave low 
yield.  Hence, we focused the three component one pot synthesis by using beta- nitrostyrenes which 
was made by reported method.23,24  Optimization table for three component (Table 1) and four 
component (Table 2) is given below. 
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Table1. One- pot three component synthesis of methyl 4-oxo-2-phenyl-4H-pyrrolo[2,1-
c][1,4]benzoxazine-3-carboxylate (6) from 2-aminophenol (1), dimethylacetylene dicarboxylate 
(2), and beta-nitrostyrene (4). 
 
 
 
Entry Solvent Catalyst Time(hours.) Yield(%) 
1 DCM Acetic acid (1 equiv.) 12 - 
2 Toluene Acetic acid (1 equiv.) 12 35 
3 Toluene Acetic acid (1.5 equiv. 12 35 
4 Toluene Acetic acid (2 equiv.) 12 35 
5 Toluene TFA (1 equiv.) 12 43 
6 Toluene p-TSA (0.2 equiv.) 12 32 
7 Toluene NEt3 (0.5 equiv.) 12 10 
8 Ethanol Acetic acid (1 equiv.) 12 30 
9 Water TBAI (1 equiv.) 12 21 
10 PEG 400 Acetic acid (1 equiv.) 12 45 
11 PEG 400 FeCl3 (0.1 equiv.) 12 66 
12 Acetic acid Acetic acid (1 ml.) 12 60 
13 Acetonitrile FeCl3 (0.1equiv) 12 15 
14 Acetonitrile L-proline (1 equiv.) 12 12 
15 Acetonitrile I2  (1 equiv.) 7 85 
16 Acetonitrile FeCl3 (0.1 equiv.) 7 73 
17 Acetonitrile FeCl3 (0.1 equiv.)  
piperidine (0.5 equiv.) 
7 13 
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Table 2. One-pot four component synthesis of methyl 4-oxo-2-phenyl-4H-pyrrolo[2,1-
c][1,4]benzoxazine-3-carboxylate (7) from 2-aminophenol (1), dimethyl acetylene dicarboxylate 
(2),  nitromethane (3), and benzaldehyde (5). 
 
 
 
 
Entry Solvent Catalyst Time(hours) Yield (%) 
1 CH3NO2 (2 ml) I2 (1 equiv.) 7                30 
2 CH3NO2 (2 ml) I2 (0.2 equiv.) 7 10a 
3 CH3NO2 (2 ml) I2 (0.2 equiv.) 7 - 
4 CH3NO2 (2 ml) I2 (0.5 equiv.) 7 - 
5 CH3NO2 (2 ml) I2 (0.2 equiv.) &  
acetic acid (1 equiv.) 
7 - 
6 CH3NO2(2 ml) I2 (0.2 equiv.) &  
acetic acid (5 equiv.) 
7 - 
7 CH3NO2 (2 ml) I2 (0.2 equiv.) &  
triflic acid (1equiv.) 
12 12 
8 CH3NO2 (2 ml) I2 (0.2equiv) &  
triflic acid (5 equiv.) 
12 15 
9 [bmIm]Br [bmIm]Br (3 equiv.) 7 26 
10 CH3NO2 (0.5 ml) FeCl3 (0.1equiv.) 7 10 
 
a microwave(250Watt, 100 OC, 250psi). 
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Table 3. The scope of 2-aminophenol, acetylenic esters and substituted beta-nitrostyrenes. 
  
 
Entry R Z Product Time (hours) Yield(%) 
1 Me H (3a) 4a 6.5 85 
2 Et H (3a) 4b 7 83 
3 Me  4-Cl (3b) 4c 4 86 
4 Et     4-Cl (3b) 4d 4.25 82 
5 Me 2-F,4-Br 
(3c) 
4e 4 82 
6 Et 2-F,4-Br 
(3c)  
4f 4.5 81 
7 Me 4-Et (3d) 4g 4 82 
8 Et 4-Et (3d) 4h 4.2 84 
 
 
After successful accomplishment of this method we turned to the illustration of the reaction 
mechanism (Figure 3).  Based on the above result a plausible mechanism for the formation of 
pyrrolo-1,4-benzoxazine has been proposed. The reaction between 2-aminophenol and 
dialkylacetylenedicarboxylate affords benzoxazine intermediate,  The resulting intermediate reacts 
with nitrostyrene in the presence of iodine followed by formation of iminium ion which then 
undergoes a series of cyclisation and elimination reaction to generate our desired product. 
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                                                        Figure 3. Plausible reaction mechanism 
 
 
 
1.5 CONCLUSION 
In summary, we have successfully developed I2 mediated novel, simple, economic, 
environmental friendly one pot three component reaction to synthesize medicinally and 
biologically important pyrrolo-1,4-benzoxazine.  There are several advantages associated with this 
method (i) easy accessibility of pyrrolo-1,4-benzoxazine by mixing all three starting material 
without inert atmosphere, (ii) easy work-ups, (iii) metal, acid and base free synthesis and (iv) non 
moisture sensitive.  This methodology might be the best alternative for existing literature methods. 
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1.6 EXPERIMENTAL SECTION 
 
General information 
 
 In this section the preparation of all the compounds that have been made in the course of 
synthesis of substituted pyrroles and the optimization process is discussed. For experiment all the 
starting material and reagents are purchased from standard commercial source or were prepared in 
laboratory. All the glasswares were cleaned with soap water followed by acetone and dried in hot 
air oven at 100 OC for 2 hrs. Solvent were distilled prior to use; petroleum ether with a boiling 
point range 40-60 OC was used. 
IR spectra were recorded on the Bruker Tensor 37(FTIR) spectrophotometer. 1H NMR 
spectra were recorded on Bruker Avance 400 (400 MHz) spectrometer at 295K in CDCl3;  
chemical shifts value (δ ppm) and coupling constants (Hz) are reported in standard fashion with 
reference to either tetramethylsilane (TMS) (δH = 0.00 ppm) or CHCl3 (δH = 7.26ppm). 13C NMR 
spectra were recorded on Bruker Avance 400 (100 MHz) spectrometer at 298K in CDCl3;  
chemical shifts (δ ppm) are reported relative to CHCl3 [(δC=77.00ppm) central line of triplet].  In 
13C NMR the nature of carbons (C, CH, CH2, and CH3) was determined by recording the DEPT- 
135 spectra.  In 1H NMR, the following abbreviations were used throughout the thesis; s = singlet, 
d = doublet, t = triplet, q = quartet, qui = quintet, m = multiplet and br.s = broad singlet. The 
assignment of the signals was confirmed by 1H, 13C and DEPT spectra.  Reactions were monitored 
by TLC on silica gel (254 mesh) using a combination of petroleum ether and ethyl acetate as 
eluents. 
 
Representative experimental procedure for the synthesis of methyl 4-oxo-2-phenyl-4H-
pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate (Table 2, 4a). To a mixture of 2-aminophenol 
(100mg, 0.92mmol), dimethyl acetylene dicarboxylate (130.7mg, 0.92mmol) in acetonitrile stirred 
for 15mins under rt. After formation of the intermediate conforming by TLC beta-nitrostyrene 
(137.2mg, 0.92   mmol), Iodine (233.7mg, 1eq.) was added and the resulting mixture was refluxed 
for 6.5hrs. The reaction completion was monitored by TLC with pet ether-ethyl acetate as eluent. 
After completion of the reaction, reaction mixture was extracted using ethyl acetate and the extract 
was washed with 20% aqueous Na2S2O3 solution to remove excess iodine, dried over anhydrous 
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Na2SO4 and concentrated under reduced pressure. The crude extract was purified by filtration 
through a silica gel (100-200 mesh) column using pet ether/ EtOAc (80 : 20) to yield the desired 
product 4a as white solid (85% yield) and spectroscopic data matching with the reported literature 
data.                                             
All reaction for the synthesis of pyrrolo 1,4-benzoxazines were carried out following this 
representative procedure. 
 
Representative experimental procedure for the synthesis of substituted beta-nitrostyrenes 
(3a, 3c, 3d, 3e): 
A solution of 1 equiv. substituted benzaldehyde and 1 equiv. of nitromethane in 4 ml. of    
methanol was cooled to 5 OC in an ice-bath.  5ml of ice-cold aqueous solution of sodium hydroxide, 
containing 690mg of NaOH, was added dropwise with stirring at such a rate that the temperature 
was maintained between 10 to 15 OC. A white precipitate occurred which upon addition of about 
two-thirds of the NaOH solution became too thick for efficient stirring.  An additional 2 ml. of 
methanol was added and stirring continued for 15 min. after all the NaOH solution had been added.  
A water-ice mixture (12 ml.) was added and the resulting solution was slowly added with stirring 
to a mixture of 3.1 ml. of concentrated hydrochloric acid and 5.9 ml. of water. The resulting 
precipitate was washed to free of chloride, giving of dry crude product.  Recrystallization have 
done from 95% ethanol. 
 
Representative experimental procedure for the synthesis of substituted beta-nitrostyrene 
(3b): 
1.1 equiv. of nitromethane and 1 equiv. of substituted benzaldehyde, 0.5 equiv. ammonium 
acetate in 2 ml. of glacial acetic acid was heated under reflux for 1hours.  The hot mixture was 
poured into 30 ml. of ice- water mixture. The resulting precipitate was washed with water and 
recrystallized from a mixture of 95% ethanol and acetone(2:1). 
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1.7 SPECTRAL DATA 
 
 
Methyl 4-oxo-2-phenyl-4H-pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate (4a): pale yellow 
powder  (85%); mp 185-187 OC. 1H NMR (CDCl3, 400MHz): δ = 3.92 (s, 3H, CH3), 7.3-7.43 (m, 
6H, ArH), 7.45-7.51 (m, 2H, ArH), 7.61-7.67 (m, 1H, ArH), 7.69 (s, 1H, ArH) ppm. 13C NMR 
(CDCl3, 100MHz): δ = 165.47, 152.36, 143.41, 132.33, 129.79, 129.11, 128.28, 128.07, 127.53, 
125.399, 122.40, 121.91, 118.75, 116.14, 115.97, 114.75, 53.16 ppm.  
 
 
 
Ethyl 4-oxo-2-phenyl-4H-pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate (4b) : pale yellow 
powder (83%); mp   170-172 OC. 1H NMR (CDCl3, 400MHz): δ = 1.31 (t, 3H, J=7.09Hz, CH3), 
4.41 (q, 2H, J=7.01Hz, CH2), 7.28-7.42 (m, 6H, ArH), 7.44-7.51 (m, 2H, ArH), 7.59-7.66 (m, 1H, 
ArH), 7.68 (s, 1H, ArH) ppm. 13C NMR (CDCl3, 100MHz): δ = 164.71, 152.06, 143.09, 132.10, 
129.30, 128.74, 127.93, 127.85, 127.18, 125.09, 122.58, 121.63, 118.39, 115.70, 114.47, 61.98, 
13.95 ppm. 
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Methyl 2-(4-chlorophenyl)-4-oxo-4H-pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate (4c): pale 
yellow powder (86%); mp 186-188 OC. 1H NMR (CDCl3, 400MHz): δ = 3.93 (s, 3H, CH3), 7.32-
7.46 (m, 7H, ArH), 7.61-7.74 (m, 2H, ArH) ppm. 13C NMR (CDCl3, 100MHz): δ = 164.76,158.53, 
151.97, 143.18, 134.14, 130.06, 129.22, 129.06, 128.34, 127.45, 125.19, 122.03, 121.55, 116.10, 
115.66, 114.48, 52.88 ppm. 
 
 
Ethyl 2-(4-chlorophenyl)-4-oxo-4H-pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate (4d): pale 
yellow powder (82%); mp   170-172 OC. 1H NMR (CDCl3, 400MHz): δ = 1.32 (t, J=7.09 Hz, 3 H, 
CH3), 4.41 (q, J=7.34 Hz, 2 H, CH2) 7.30 - 7.44 (m, 7 H, ArH), 7.64 (dd, J=7.82, 1.96 Hz, 1 H, 
ArH), 7.66 - 7.69 (m, 1 H, ArH) ppm. 13C NMR (CDCl3, 100MHz): δ = 164.47, 151.94, 143.14, 
134.04, 130.63, 129.22, 128.96, 128.47, 128.16, 127.37, 125.15, 122.47, 121.53, 118.53, 115.97, 
115.62, 114.45, 13.97 ppm. 
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Methyl 2-(4-bromo-2-fluorophenyl)-4-oxo-4H-pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate 
(4e): pale yellow powder (82%); mp   192-194 OC. 1H NMR (CDCl3, 400MHz): δ = 3.92 (s, 3H, 
CH3), 7.31-7.44 (m, 6H, ArH), 7.66 (dd, 1H, J=8.07, 1.71 Hz, ArH), 7.77 (d, 1H, J=1.47 Hz, ArH) 
ppm. 13C NMR (CDCl3, 100MHz): δ = 164.57, 158.15, 151.69, 143.18, 131.28, 127.84, 127.61, 
125.19, 121.98, 121.42, 119.79, 119.28, 118.55, 117.19, 114.58, 52.86 ppm. 
 
 
 
Ethyl 2-(4-bromo-2-fluorophenyl)-4-oxo-4H-pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate 
(4f): pale yellow powder (81%); mp   184-186 ○C. 1H NMR (CDCl3, 400MHz): δ = 1.30 (t, J=7.34 
Hz, 3 H, CH3) 4.39 (q, J=7.34 Hz, 2 H, CH2) 7.29 - 7.39 (m, 6 H, ArH) 7.61 - 7.67 (m, 1 H, ArH) 
7.75 (d, J=0.98 Hz, 1 H, ArH)ppm. 13C NMR (CDCl3, 100MHz): δ = 163.86, 158.13, 151.63, 
143.09, 131.38, 127.76, 127072, 127.53, 125.16, 121.84, 121.36, 1199.66, 119.43, 118.41, 117.23, 
114.58, 61.94, 13.92 ppm. 
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Methyl 2-(4-ethylphenyl)-4-oxo-4H-pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate (4g): pale 
yellow powder (82%); mp   166-168 OC. 1H NMR (CDCl3, 400MHz): δ = 1.25 (t, J=7.58 Hz, 3 H, 
CH3), 2.66 (q, J=7.50 Hz, 2 H, CH2) 3.93 (s, 3 H, CH3) 7.20 - 7.40 (m, 7 H, ArH) 7.60 - 7.63 (m, 
1 H, ArH) 7.66 (s, 1 H, ArH) ppm. 13C NMR (CDCl3, 100MHz): δ = 165.40, 152.13, 144.16, 
143.06, 129.36, 129.28, 128.35, 127.64, 127.14, 125.20, 121.96, 121.62, 118.388, 115.73, 115.60, 
114.48, 52.90, 28.58, 15.43 ppm. 
 
 
 
 Ethyl 2-(4-ethylphenyl)-4-oxo-4H-pyrrolo[2,1-c][1,4]benzoxazine-3-carboxylate (4h): pale 
yellow powder (84%); mp   162-164 ○C. 1H NMR (CDCl3, 400MHz): δ = 1.22 - 1.27 (m, 3 H) 
1.33 (t, J=7.09 Hz, 3 H) 2.65 (q, J=7.34 Hz, 2 H) 4.42 (q, J=7.17 Hz, 2 H) 7.19 (m, J=8.31 Hz, 2 
H) 7.27 - 7.35 (m, 3 H) 7.36 - 7.40 (m, 2 H) 7.57 - 7.62 (m, 1 H) 7.65 (s, 1 H) ppm. 13C NMR 
(CDCl3, 100MHz): δ = 164.92, 152.11, 144.10, 143.02, 129.32, 129.23, 128.25, 127.69, 127.09, 
125.07, 122.42, 121.61, 118.30, 115.60, 114.48, 61.98, 28.57, 15.47, 13.99 ppm. 
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Figure 4. 1H NMR (400MHz) spectrum of compound 4a in CDCl3. 
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Figure 5.  13C NMR (100MHz) spectrum of compound 4a in CDCl3. 
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Figure 6. 1H NMR (400MHz) spectrum of compound 4b in CDCl3. 
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. Figure 7.  13C NMR (100MHz) spectrum of compound 4b in CDCl3. 
 
27 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
2.976.991.85
7
.6
8
7
.6
4
7
.4
3
7
.4
3
7
.4
1
7
.4
1
7
.4
0
7
.3
8
7
.3
6
3
.9
3
0
.0
0
 
Figure 8. 1H NMR (400MHz) spectrum of compound 4c in CDCl3. 
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Figure 9 .  13C NMR (100MHz) spectrum of compound 4c in CDCl3. 
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Figure 10. 1H NMR (400MHz) spectrum of compound 4d in CDCl3. 
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Figure 11.  13C NMR (100MHz) spectrum of compound 4d in CDCl3. 
29 
 
 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
2.986.000.980.99
7
.7
6
7
.6
5
7
.6
5
7
.4
1
7
.3
8
7
.3
7
7
.3
5
7
.3
5
7
.3
5
7
.3
4
3
.9
2
0
.0
0
 
Figure 12. 1H NMR (400MHz) spectrum of compound 4e in CDCl3 
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Figure 13.  13C NMR (100MHz) spectrum of compound 4e in CDCl3. 
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Figure 14. 1H NMR (400MHz) spectrum of compound 4f in CDCl3. 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20
Chemical Shift (ppm)
1
6
3
.8
8
1
5
8
.1
3
1
5
1
.6
3
1
4
3
.0
9
1
3
1
.3
8
1
2
7
.7
6
1
2
7
.7
2
1
2
7
.5
3
1
2
5
.1
6
1
2
1
.8
4
1
2
1
.3
6
1
1
9
.6
8
1
1
9
.4
3
1
1
8
.4
1
1
1
7
.2
3
1
1
4
.5
8
7
7
.3
8
7
7
.0
6
7
6
.7
4
6
1
.9
4
1
3
.9
2
 
Figure 15.  13C NMR (100MHz) spectrum of compound 4f in CDCl3. 
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Figure 16. 1H NMR (400MHz) spectrum of compound 4g in CDCl3. 
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Figure 17.  13C NMR (100MHz) spectrum of compound 4g in CDCl3. 
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Figure 18. 1H NMR (400MHz) spectrum of compound 4h in CDCl3. 
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Figure 19.  13C NMR (100MHz) spectrum of compound 4h in CDCl3. 
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